{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"Earlier. Smarter. Stronger \u26a1 \u2014 \ud83e\udec0 \u2014 The 2026 ACC\/AHA Dyslipidemia Playbook","description":"\ud83e\udec0 The 2026 ACC\/AHA Multisociety Guideline on the Management of Dyslipidemia marks a major shift in preventive cardiology. Key updates include universal Lp(a) testing at least once in adulthood, greater emphasis on ApoB, adoption of the PREVENT risk equations, return of LDL-C treatment goals, and more aggressive use of nonstatin therapies to achieve risk-based targets. The message is simple: identify risk earlier, lower atherogenic lipoproteins more effectively, and prevent ASCVD before it occurs. \ud83d\udcda A landmark roadmap for clinicians committed to precision cardiovascular prevention. #Cardiology #PreventiveCardiology #Lipidology #ASCVD #MedicalEducation #MedicalPodcasts Reference: Blumenthal RS et al. 2026 ACC\/AHA Multisociety Guideline on the Management of Dyslipidemia. JACC 2026. ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41596340\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/202835265"}